001     128845
005     20240228143352.0
024 7 _ |a 10.1016/j.ccell.2016.02.001
|2 doi
024 7 _ |a pmid:26923874
|2 pmid
024 7 _ |a 1535-6108
|2 ISSN
024 7 _ |a 1878-3686
|2 ISSN
024 7 _ |a altmetric:6004102
|2 altmetric
037 _ _ |a DKFZ-2017-04858
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Johann, Pascal
|0 P:(DE-He78)3fdc3623477264cb5d0e14f256dbfbb8
|b 0
|e First author
|u dkfz
245 _ _ |a Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.
260 _ _ |a Cambridge, Mass.
|c 2016
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1521808724_5360
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Atypical teratoid/rhabdoid tumor (ATRT) is one of the most common brain tumors in infants. Although the prognosis of ATRT patients is poor, some patients respond favorably to current treatments, suggesting molecular inter-tumor heterogeneity. To investigate this further, we genetically and epigenetically analyzed 192 ATRTs. Three distinct molecular subgroups of ATRTs, associated with differences in demographics, tumor location, and type of SMARCB1 alterations, were identified. Whole-genome DNA and RNA sequencing found no recurrent mutations in addition to SMARCB1 that would explain the differences between subgroups. Whole-genome bisulfite sequencing and H3K27Ac chromatin-immunoprecipitation sequencing of primary tumors, however, revealed clear differences, leading to the identification of subgroup-specific regulatory networks and potential therapeutic targets.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Chromosomal Proteins, Non-Histone
|2 NLM Chemicals
650 _ 7 |a DNA-Binding Proteins
|2 NLM Chemicals
650 _ 7 |a SMARCB1 Protein
|2 NLM Chemicals
650 _ 7 |a SMARCB1 protein, human
|2 NLM Chemicals
650 _ 7 |a Transcription Factors
|2 NLM Chemicals
700 1 _ |a Erkek, Serap
|0 P:(DE-He78)df8660bc5aba525f7fb6dba4aac15c1c
|b 1
|u dkfz
700 1 _ |a Zapatka, Marc
|0 P:(DE-He78)1beba8f953e7ae7e96e8d3e9a48f10f7
|b 2
|u dkfz
700 1 _ |a Kerl, Kornelius
|b 3
700 1 _ |a Buchhalter, Ivo
|b 4
700 1 _ |a Hovestadt, Volker
|0 P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc
|b 5
|u dkfz
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 6
|u dkfz
700 1 _ |a Sturm, Dominik
|0 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
|b 7
|u dkfz
700 1 _ |a Hermann, Carl
|b 8
700 1 _ |a Segura Wang, Maia
|b 9
700 1 _ |a Korshunov, Andrey
|0 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
|b 10
|u dkfz
700 1 _ |a Rhyzova, Marina
|b 11
700 1 _ |a Gröbner, Susanne
|0 P:(DE-He78)932918ed0e8d8790a81235528019a8e0
|b 12
|u dkfz
700 1 _ |a Brabetz, Sebastian
|0 P:(DE-He78)b0b3740107f746e09dc23fdf25eb0629
|b 13
|u dkfz
700 1 _ |a Chavez, Lukas
|0 P:(DE-He78)082dd3179733e3e716a58eb90f418a78
|b 14
|u dkfz
700 1 _ |a Bens, Susanne
|b 15
700 1 _ |a Gröschel, Stefan
|0 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f
|b 16
|u dkfz
700 1 _ |a Kratochwil, Fabian
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Wittmann, Andrea
|0 P:(DE-He78)adf0bc22f6c87d09ddb939645a7870ed
|b 18
|u dkfz
700 1 _ |a Sieber, Laura
|0 P:(DE-He78)a4101d4d75f0b7d1f24f67ccbe63164b
|b 19
|u dkfz
700 1 _ |a Geörg, Christina
|b 20
700 1 _ |a Wolf, Stefan
|0 P:(DE-HGF)0
|b 21
700 1 _ |a Beck, Katja
|0 P:(DE-He78)f6b238ac374345c55706521c4f435779
|b 22
|u dkfz
700 1 _ |a Oyen, Florian
|b 23
700 1 _ |a Capper, David
|0 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
|b 24
|u dkfz
700 1 _ |a van Sluis, Peter
|b 25
700 1 _ |a Volckmann, Richard
|b 26
700 1 _ |a Koster, Jan
|b 27
700 1 _ |a Versteeg, Rogier
|b 28
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 29
|u dkfz
700 1 _ |a Milde, Till
|0 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f
|b 30
|u dkfz
700 1 _ |a Witt, Olaf
|0 P:(DE-He78)143af26de9d57bf624771616318aaf7c
|b 31
|u dkfz
700 1 _ |a Kulozik, Andreas E
|b 32
700 1 _ |a Ebinger, Martin
|b 33
700 1 _ |a Shalaby, Tarek
|b 34
700 1 _ |a Grotzer, Michael
|b 35
700 1 _ |a Sumerauer, David
|b 36
700 1 _ |a Zamecnik, Josef
|b 37
700 1 _ |a Mora, Jaume
|b 38
700 1 _ |a Jabado, Nada
|b 39
700 1 _ |a Taylor, Michael D
|b 40
700 1 _ |a Huang, Annie
|b 41
700 1 _ |a Aronica, Eleonora
|b 42
700 1 _ |a Bertoni, Anna
|0 P:(DE-HGF)0
|b 43
700 1 _ |a Radlwimmer, Bernhard
|0 P:(DE-He78)d1939d434dd885fad08106329e3db719
|b 44
|u dkfz
700 1 _ |a Pietsch, Torsten
|b 45
700 1 _ |a Schüller, Ulrich
|b 46
700 1 _ |a Schneppenheim, Reinhard
|b 47
700 1 _ |a Northcott, Paul A
|0 P:(DE-HGF)0
|b 48
700 1 _ |a Korbel, Jan O
|b 49
700 1 _ |a Siebert, Reiner
|b 50
700 1 _ |a Frühwald, Michael C
|b 51
700 1 _ |a Lichter, Peter
|0 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
|b 52
|u dkfz
700 1 _ |a Eils, Roland
|0 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0
|b 53
|u dkfz
700 1 _ |a Gajjar, Amar
|b 54
700 1 _ |a Hasselblatt, Martin
|b 55
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 56
|u dkfz
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 57
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.ccell.2016.02.001
|g Vol. 29, no. 3, p. 379 - 393
|0 PERI:(DE-600)2074034-7
|n 3
|p 379 - 393
|t Cancer cell
|v 29
|y 2016
|x 1535-6108
909 C O |o oai:inrepo02.dkfz.de:128845
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)3fdc3623477264cb5d0e14f256dbfbb8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)df8660bc5aba525f7fb6dba4aac15c1c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)1beba8f953e7ae7e96e8d3e9a48f10f7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)744146d3b5a3df1e0ac555e5bf1ee5cc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)551bb92841f634070997aa168d818492
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)932918ed0e8d8790a81235528019a8e0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)b0b3740107f746e09dc23fdf25eb0629
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)082dd3179733e3e716a58eb90f418a78
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)5120a331b1c28045c8ca6a8b1c73c95f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)adf0bc22f6c87d09ddb939645a7870ed
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)a4101d4d75f0b7d1f24f67ccbe63164b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)f6b238ac374345c55706521c4f435779
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 24
|6 P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)143af26de9d57bf624771616318aaf7c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 43
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 44
|6 P:(DE-He78)d1939d434dd885fad08106329e3db719
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 48
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 52
|6 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 53
|6 P:(DE-He78)78b6aa82148e60b4d91e3a37a6d3d9a0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 56
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 57
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2016
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CELL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b CANCER CELL : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)B060-20160331
|k B060
|l Molekulare Genetik
|x 1
920 1 _ |0 I:(DE-He78)G380-20160331
|k G380
|l KKE Neuropathologie
|x 2
920 1 _ |0 I:(DE-He78)G340-20160331
|k G340
|l KKE Pädiatrische Onkologie
|x 3
920 1 _ |0 I:(DE-He78)G240-20160331
|k G240
|l Molekulare Leukämogenese
|x 4
920 1 _ |0 I:(DE-He78)G100-20160331
|k G100
|l Translationale Onkologie
|x 5
920 1 _ |0 I:(DE-He78)B069-20160331
|k B069
|l Zentrum für personalisierte Medizin
|x 6
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)B060-20160331
980 _ _ |a I:(DE-He78)G380-20160331
980 _ _ |a I:(DE-He78)G340-20160331
980 _ _ |a I:(DE-He78)G240-20160331
980 _ _ |a I:(DE-He78)G100-20160331
980 _ _ |a I:(DE-He78)B069-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21